Ambag, Ronelyn A.

HRN: 26-89-87  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/30/2025
CEFUROXIME 500MG (TAB)
03/30/2025
04/06/2025
ORAL
500mg
BID
SP NSVD RMLE WITH EPISIORRAPHY
Waiting Final Action 
03/31/2025
CEFUROXIME 500MG (TAB)
03/31/2025
04/07/2025
ORAL
500 Mg/tab
BID
S/p Nsd With Rmle
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: